Acciones Fluoropharma Medical Inc OTC Bulletin Board
Acciones
Biotecnología e investigación médica
Ventas 2015 | - | Ventas 2016 | - | Capitalización | 3,8 M 3,53 M |
---|---|---|---|---|---|
Resultado Neto 2015 | -3 M -2,79 M | Resultado Neto 2016 | -2 M -1,86 M | VE / Ventas 2015 | - |
Deuda neta 2015 | 4,19 M 3,9 M | Deuda neta 2016 | 5,8 M 5,39 M | VE / Ventas 2016 | - |
P/E ratio 2015 |
-2,41
x | P/E ratio 2016 |
-1,45
x | Empleados | - |
Rendimiento 2015 * |
-
| Rendimiento 2016 |
-
| Flotante | 99,97 % |
Directores | Puesto | Edad | Desde |
---|---|---|---|
Ambrose Egbuonu
CEO | Chief Executive Officer | - | 16/05/22 |
Frank Igwealor
DFI | Director of Finance/CFO | 53 | 16/05/22 |
Chairman | 78 | 14/02/11 |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Chairman | 78 | 14/02/11 | |
William Lewis
BRD | Director/Board Member | 48 | 06/11/15 |
Frank Igwealor
DFI | Director of Finance/CFO | 53 | 16/05/22 |
Varia. 1 de ene. | Capi. | |
---|---|---|
+25,69 % | 48,09 mil M | |
+46,90 % | 40,62 mil M | |
-3,46 % | 40,43 mil M | |
-6,20 % | 28,36 mil M | |
+9,17 % | 24,89 mil M | |
-20,42 % | 19,01 mil M | |
+28,07 % | 12,09 mil M | |
+0,17 % | 11,88 mil M | |
-1,24 % | 11,8 mil M |